{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:28:58Z","timestamp":1784647738330,"version":"3.55.0"},"reference-count":82,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,17]]},"abstract":"<jats:p>Defining features of chronic airway diseases include abnormal and persistent inflammatory processes, impaired airway epithelial integrity and function, and increased susceptibility to recurrent respiratory infections. Phosphoinositide 3-kinases (PI3K) are lipid kinases, which contribute to multiple physiological and pathological processes within the airway, with abnormal PI3K signalling contributing to the pathogenesis of several respiratory diseases. Consequently, the potential benefit of targeting PI3K isoforms has received considerable attention, being viewed as a viable therapeutic option in inflammatory and infectious lung disorders. The class I PI3K isoform, PI3K\u03b4 (Phosphoinositide 3-kinases \u03b4) is of particular interest given its multiple roles in modulating innate and adaptive immune cell functions, airway inflammation and corticosteroid sensitivity. In this mini-review, we explore the role of PI3K\u03b4 in airway inflammation and infection, focusing on oxidative stress, ER stress, histone deacetylase 2 and neutrophil function. We also describe the importance of PI3K\u03b4 in adaptive immune cell function, as highlighted by the recently described Activated PI3K Delta Syndrome, and draw attention to some of the potential clinical applications and benefits of targeting this molecule.<\/jats:p>","DOI":"10.1042\/bst20170467","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T01:30:20Z","timestamp":1520645420000},"page":"361-369","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Phosphoinositide 3-kinase \u03b4 (PI3K\u03b4) in respiratory disease"],"prefix":"10.1042","volume":"46","author":[{"given":"Clare A.","family":"Stokes","sequence":"first","affiliation":[{"name":"Department of Infection, Immunity and Cardiovascular Disease, School of Medicine, Dentistry and Health, University of Sheffield, Sheffield, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Condliffe","sequence":"additional","affiliation":[{"name":"Department of Infection, Immunity and Cardiovascular Disease, School of Medicine, Dentistry and Health, University of Sheffield, Sheffield, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"2021111818093145400_BST-2017-0467CC1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev-pathol-012615-044344","article-title":"Bronchiectasis: current concepts in pathogenesis, immunology, and microbiology","volume":"11","author":"Boyton","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"2021111818093145400_BST-2017-0467CC3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1165\/rcmb.2013-0348TR","article-title":"Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung","volume":"50","author":"Nyunoya","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2021111818093145400_BST-2017-0467CC4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1165\/rcmb.2014-0019TR","article-title":"The integrated stress response in lung disease","volume":"50","author":"van \u2018t Wout","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2021111818093145400_BST-2017-0467CC5","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1164\/ajrccm.155.5.9154890","article-title":"Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells","volume":"155","author":"Mio","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC6","doi-asserted-by":"publisher","first-page":"L230","DOI":"10.1152\/ajplung.00382.2016","article-title":"Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD","volume":"313","author":"Yanagisawa","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2021111818093145400_BST-2017-0467CC7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1165\/rcmb.2012-0492TR","article-title":"The neutrophil in chronic obstructive pulmonary disease","volume":"48","author":"Hoenderdos","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2021111818093145400_BST-2017-0467CC8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1513\/pats.200605-104SF","article-title":"Cell death, remodeling, and repair in chronic obstructive pulmonary disease?","volume":"3","author":"Henson","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"2021111818093145400_BST-2017-0467CC9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/resp.12542","article-title":"Bronchial epithelial cells: the key effector cells in the pathogenesis of chronic obstructive pulmonary disease?","volume":"20","author":"Gao","year":"2015","journal-title":"Respirology"},{"key":"2021111818093145400_BST-2017-0467CC10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/cells5040040","article-title":"Airway epithelial cell cilia and obstructive lung disease","volume":"5","author":"Yaghi","year":"2016","journal-title":"Cells"},{"key":"2021111818093145400_BST-2017-0467CC11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1378\/chest.11-2348","article-title":"Defective phagocytosis in airways disease","volume":"141","author":"Donnelly","year":"2012","journal-title":"Chest"},{"key":"2021111818093145400_BST-2017-0467CC12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201111-2075OC","article-title":"The lung tissue microbiome in chronic obstructive pulmonary disease","volume":"185","author":"Sze","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","article-title":"Lung microbiome dynamics in COPD exacerbations","volume":"47","author":"Wang","year":"2016","journal-title":"Eur. Respir. J."},{"key":"2021111818093145400_BST-2017-0467CC14","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00281-016-0561-5","article-title":"COPD immunopathology","volume":"38","author":"Caramori","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"2021111818093145400_BST-2017-0467CC16","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","article-title":"Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease","volume":"340","author":"Niewoehner","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"2021111818093145400_BST-2017-0467CC17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/COPD.S51012","article-title":"Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease","volume":"9","author":"Woods","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"2021111818093145400_BST-2017-0467CC18","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2021111818093145400_BST-2017-0467CC19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa1407154","article-title":"Withdrawal of inhaled glucocorticoids and exacerbations of COPD","volume":"371","author":"Magnussen","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2021111818093145400_BST-2017-0467CC20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"2021111818093145400_BST-2017-0467CC21","doi-asserted-by":"publisher","first-page":"1362.e1","DOI":"10.1016\/j.amjmed.2015.07.032","article-title":"Azithromycin for the prevention of COPD exacerbations: the good, bad, and ugly","volume":"128","author":"Taylor","year":"2015","journal-title":"Am. J. Med."},{"key":"2021111818093145400_BST-2017-0467CC22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.chest.2016.08.1451","article-title":"Macrolides for clinically significant bronchiectasis in adults: who should receive this treatment?","volume":"150","author":"Hill","year":"2016","journal-title":"Chest"},{"key":"2021111818093145400_BST-2017-0467CC23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12325-015-0215-3","article-title":"Feasibility of computed tomography in a multicenter COPD trial: a study of the effect of AZD9668 on structural airway changes","volume":"32","author":"Nordenmark","year":"2015","journal-title":"Adv. Ther."},{"key":"2021111818093145400_BST-2017-0467CC24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.rmed.2012.12.009","article-title":"Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis","volume":"107","author":"Stockley","year":"2013","journal-title":"Respir. Med."},{"key":"2021111818093145400_BST-2017-0467CC25","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2147\/DDDT.S105207","article-title":"Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature","volume":"11","author":"Parr","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"2021111818093145400_BST-2017-0467CC26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm3290","article-title":"PI3K signalling: the path to discovery and understanding","volume":"13","author":"Vanhaesebroeck","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021111818093145400_BST-2017-0467CC27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1124\/jpet.108.144311","article-title":"Aerosolized phosphoinositide 3-kinase \u03b3\/\u03b4 inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease","volume":"328","author":"Doukas","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021111818093145400_BST-2017-0467CC28","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.chembiol.2013.09.017","article-title":"PI3K-\u03b4 and PI3K-\u03b3 inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models","volume":"20","author":"Winkler","year":"2013","journal-title":"Chem. Biol."},{"key":"2021111818093145400_BST-2017-0467CC29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1096\/fj.05-5045com","article-title":"Inhibition of phosphoinositide 3-kinase \u03b4 attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model","volume":"20","author":"Lee","year":"2006","journal-title":"FASEB J."},{"key":"2021111818093145400_BST-2017-0467CC30","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1183\/09031936.00106609","article-title":"Phosphoinositide 3-kinase \u03b4 inhibitor suppresses interleukin-17 expression in a murine asthma model","volume":"36","author":"Park","year":"2010","journal-title":"Eur. Respir. J."},{"key":"2021111818093145400_BST-2017-0467CC31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/eji.200636401","article-title":"Role of the phosphoinositide 3-kinase p110\u03b4 in generation of type 2 cytokine responses and allergic airway inflammation","volume":"37","author":"Nashed","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pupt.2017.08.008","article-title":"Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3K\u03b4 inhibitor under development for the treatment of COPD","volume":"46","author":"Cahn","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"2021111818093145400_BST-2017-0467CC33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2017.09.028","article-title":"Oxidative stress in early cystic fibrosis lung disease is exacerbated by airway glutathione deficiency","volume":"113","author":"Dickerhof","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"2021111818093145400_BST-2017-0467CC34","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1021\/bi0205911","article-title":"Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt","volume":"42","author":"Qin","year":"2003","journal-title":"Biochemistry"},{"key":"2021111818093145400_BST-2017-0467CC35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","article-title":"Targeting phosphoinositide-3-kinase-\u03b4 with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease","volume":"182","author":"To","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting \u03b2-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"key":"2021111818093145400_BST-2017-0467CC37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1164\/rccm.200810-1570OC","article-title":"Inhibition of PI3K\u03b4 restores glucocorticoid function in smoking-induced airway inflammation in mice","volume":"179","author":"Marwick","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1124\/jpet.110.175950","article-title":"Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-\u03b4","volume":"337","author":"Mercado","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021111818093145400_BST-2017-0467CC39","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/thx.2007.090027","article-title":"Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma","volume":"63","author":"Bhavsar","year":"2008","journal-title":"Thorax"},{"key":"2021111818093145400_BST-2017-0467CC40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1164\/rccm.200512-1930OC","article-title":"Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma","volume":"174","author":"Hew","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12931-016-0462-0","article-title":"Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma","volume":"17","author":"Wang","year":"2016","journal-title":"Respir. Res."},{"key":"2021111818093145400_BST-2017-0467CC42","doi-asserted-by":"publisher","first-page":"30384","DOI":"10.1038\/srep30384","article-title":"Dose-Dependent suppression of cytokine production from T cells by a novel phosphoinositide 3-kinase delta inhibitor","volume":"6","author":"Way","year":"2016","journal-title":"Sci. Rep."},{"key":"2021111818093145400_BST-2017-0467CC43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12931-016-0436-2","article-title":"Anti-inflammatory potential of PI3K\u03b4 and JAK inhibitors in asthma patients","volume":"17","author":"Southworth","year":"2016","journal-title":"Respir. Res."},{"key":"2021111818093145400_BST-2017-0467CC44","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/1440-1681.12784","article-title":"An investigation of the anti-inflammatory effects and a potential biomarker of PI3K\u03b4 inhibition in COPD T cells","volume":"44","author":"Khan","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021111818093145400_BST-2017-0467CC45","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2009.02.024","article-title":"TH17-associated cytokines (IL-17A and IL-17F) in severe asthma","volume":"123","author":"Al-Ramli","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC46","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1365-2249.2009.03965.x","article-title":"T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients","volume":"157","author":"Stefano A","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1183\/09031936.00017911","article-title":"Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells","volume":"39","author":"Zijlstra","year":"2012","journal-title":"Eur. Respir. J."},{"key":"2021111818093145400_BST-2017-0467CC48","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jaci.2010.02.003","article-title":"A role for phosphoinositol 3-kinase \u03b4 in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease","volume":"125","author":"Marwick","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.intimp.2011.10.006","article-title":"Reduced glucocorticoid receptor expression and function in airway neutrophils","volume":"12","author":"Plumb","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"2021111818093145400_BST-2017-0467CC50","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1042\/BJ20112214","article-title":"Isoform-selective induction of human p110\u03b4 PI3K expression by TNF\u03b1: identification of a new and inducible PIK3CD promoter","volume":"443","author":"Whitehead","year":"2012","journal-title":"Biochem. J."},{"key":"2021111818093145400_BST-2017-0467CC51","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/jcp.23046","article-title":"The phosphoinositide 3\u2032-kinase p110\u03b4 modulates contractile protein production and IL-6 release in human airway smooth muscle","volume":"227","author":"Ge","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"2021111818093145400_BST-2017-0467CC52","first-page":"367","article-title":"Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase delta pathway","volume":"7","author":"Ueda","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"2021111818093145400_BST-2017-0467CC53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/thoraxjnl-2015-207096","article-title":"Phosphoinositide 3-kinase-\u03b4 regulates fungus-induced allergic lung inflammation through endoplasmic reticulum stress","volume":"71","author":"Lee","year":"2016","journal-title":"Thorax"},{"key":"2021111818093145400_BST-2017-0467CC54","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1164\/rccm.201308-1458OC","article-title":"Z \u03b11-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease","volume":"189","author":"Alam","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC55","doi-asserted-by":"crossref","first-page":"77685","DOI":"10.18632\/oncotarget.20768","article-title":"Inhibition of endoplasmic reticulum stress alleviates cigarette smoke-induced airway inflammation and emphysema","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"2021111818093145400_BST-2017-0467CC56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ebiom.2016.12.010","article-title":"Lyn kinase represses mucus hypersecretion by regulating IL-13-induced endoplasmic reticulum stress in asthma","volume":"15","author":"Wang","year":"2017","journal-title":"EBioMedicine"},{"key":"2021111818093145400_BST-2017-0467CC57","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1182\/blood-2005-03-0944","article-title":"Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils","volume":"106","author":"Condliffe","year":"2005","journal-title":"Blood"},{"key":"2021111818093145400_BST-2017-0467CC58","doi-asserted-by":"publisher","first-page":"e45933","DOI":"10.1371\/journal.pone.0045933","article-title":"Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival","volume":"7","author":"Juss","year":"2012","journal-title":"PLoS ONE"},{"key":"2021111818093145400_BST-2017-0467CC59","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.4049\/jimmunol.170.5.2647","article-title":"Essential role of phosphoinositide 3-kinase \u03b4 in neutrophil directional movement","volume":"170","author":"Sadhu","year":"2003","journal-title":"J. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC60","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1164\/rccm.201008-1285OC","article-title":"Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease","volume":"183","author":"Sapey","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1182\/blood-2013-08-519520","article-title":"Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence","volume":"123","author":"Sapey","year":"2014","journal-title":"Blood"},{"key":"2021111818093145400_BST-2017-0467CC62","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1182\/blood-2003-05-1667","article-title":"Mechanisms and implications of phosphoinositide 3-kinase \u03b4 in promoting neutrophil trafficking into inflamed tissue","volume":"103","author":"Puri","year":"2004","journal-title":"Blood"},{"key":"2021111818093145400_BST-2017-0467CC63","doi-asserted-by":"publisher","first-page":"e33277","DOI":"10.1371\/journal.pone.0033277","article-title":"Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD","volume":"7","author":"Vlahos","year":"2012","journal-title":"PLoS ONE"},{"key":"2021111818093145400_BST-2017-0467CC64","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1136\/thoraxjnl-2015-207604","article-title":"Hypoxia upregulates neutrophil degranulation and potential for tissue injury","volume":"71","author":"Hoenderdos","year":"2016","journal-title":"Thorax"},{"key":"2021111818093145400_BST-2017-0467CC65","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0006-291X(03)01480-3","article-title":"Selective role of PI3K\u03b4 in neutrophil inflammatory responses","volume":"308","author":"Sadhu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021111818093145400_BST-2017-0467CC66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.intimp.2016.03.027","article-title":"The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils","volume":"35","author":"Gupta","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"2021111818093145400_BST-2017-0467CC67","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"2021111818093145400_BST-2017-0467CC68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC69","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"124","author":"Deau","year":"2014","journal-title":"J. Clin. Invest."},{"key":"2021111818093145400_BST-2017-0467CC70","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K","volume":"211","author":"Lucas","year":"2014","journal-title":"J. Exp. Med."},{"key":"2021111818093145400_BST-2017-0467CC71","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.1617244114","article-title":"Conformational disruption of PI3K\u03b4 regulation by immunodeficiency mutations in PIK3CD and PIK3R1","volume":"114","author":"Dornan","year":"2017","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111818093145400_BST-2017-0467CC72","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC73","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC74","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clim.2015.12.008","article-title":"The case of an APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment","volume":"178","author":"Chiriaco","year":"2017","journal-title":"Clin. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC75","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.1073560","article-title":"Impaired B and T cell antigen receptor signaling in p110\u03b4 PI 3-kinase mutant mice","volume":"297","author":"Okkenhaug","year":"2002","journal-title":"Science"},{"key":"2021111818093145400_BST-2017-0467CC76","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.20021101","article-title":"Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination","volume":"197","author":"Suzuki","year":"2003","journal-title":"J. Exp. Med."},{"key":"2021111818093145400_BST-2017-0467CC77","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.immuni.2006.08.015","article-title":"Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling","volume":"25","author":"Omori","year":"2006","journal-title":"Immunity"},{"key":"2021111818093145400_BST-2017-0467CC78","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","article-title":"PI3K\u03b4 and primary immunodeficiencies","volume":"16","author":"Lucas","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"2021111818093145400_BST-2017-0467CC79","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.virol.2015.02.040","article-title":"The role of PI3K\/Akt in human herpesvirus infection: from the bench to the bedside","volume":"479\u2013480","author":"Liu","year":"2015","journal-title":"Virology"},{"key":"2021111818093145400_BST-2017-0467CC80","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1164\/rccm.201501-0188OC","article-title":"Targeting PI3K-p110\u03b1 suppresses influenza virus infection in chronic obstructive pulmonary disease","volume":"191","author":"Hsu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021111818093145400_BST-2017-0467CC81","doi-asserted-by":"publisher","first-page":"e0163139","DOI":"10.1371\/journal.pone.0163139","article-title":"Differential effects of p38, MAPK, PI3K or Rho kinase inhibitors on bacterial phagocytosis and efferocytosis by macrophages in COPD","volume":"11","author":"Bewley","year":"2016","journal-title":"PLoS ONE"},{"key":"2021111818093145400_BST-2017-0467CC82","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u201cactivated PI3K\u03b4 syndrome\u201d-targeted therapy with the PI3K\u03b4 inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/46\/2\/361\/434316\/bst-2017-0467c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/46\/2\/361\/434316\/bst-2017-0467c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T18:34:41Z","timestamp":1637260481000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/46\/2\/361\/67443\/Phosphoinositide-3-kinase-PI3K-in-respiratory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":82,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,3,9]]},"published-print":{"date-parts":[[2018,4,17]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20170467","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}